Advertisement · 728 × 90
#
Hashtag
#RareDiseaseMoonshot
Advertisement · 728 × 90
Post image

Welcome back to #ProjectThursday

We collect project news from the biobanking world for you every week. Enjoy! 🤝

🔗 Article: buff.ly/2wjg4d5

Today with #BigPicture #CANDLE #EPPerMed @cancerinfoportal.bsky.social #RI-SCALE #PROPHET.EU @ericforum.bsky.social #RareDiseaseMoonshot #GDI #EPND

💙🧡

0 0 0 0
Preview
Together Through the Uncommon National Conference on Rare Diseases

“BBMRI-ERIC fully supports the European priority on rare diseases: Our directory features samples/data on rare diseases, we are part of #ERDERA, contribute to the #RareDiseaseMoonshot and collaborate with #EuroBioBank.” J. Pavlic-Zupanc at the Maltese Nat. Conference on Rare Diseases

🧵 1/2

0 0 1 0
Preview
Rare diseases: a testbed for health innovation Over 30 million people in Europe live with a rare disease. Most of them still lack access to accurate diagnosis or treatment options. These unmet needs, these “white spots”, are not fringe issues.…

💡 #RareDiseaseMoonshot

As Europe discusses the future of life sciences in the context of the #EUBiotechAct, the #RareDisease Moonshot’s proposals will strengthen innovation for improved health outcomes and drive Europe’s competitiveness in life sciences

🔗 News article: buff.ly/mEC7Fet

🧵 10/12

0 0 1 0
Post image

💡 #RareDiseaseMoonshot

The Rare Disease Moonshot welcomes the European Commission’s ambition to develop a comprehensive #EUBiotechAct.

🔗 Read more: buff.ly/EbEvIkm

🧵 12/13

0 0 1 0
Preview
Rare Disease Moonshot’s contribution to the Consultation on the next Multiannual Financial Framework - Rare Disease Moonshot Introduction The Rare Disease Moonshot is a multi-stakeholder initiative uniting public and private actors, researchers, clinicians, patients, and funders to advance research and care for the 30…

💡 #RareDiseaseMoonshot

As response to the open consultation to the multiannual financial framework, the #RareDiseaseMoonshot called for a mission-oriented architecture that ensures continuity across programmes.

🔗 Read more: buff.ly/PMc13IS

🧵 12/14

0 0 1 0
Preview
Conference on 'Towards an EU action plan on rare diseases' The European Economic and Social Committee (EESC), the Polish Ministry of Health, and the Medical University of Warsaw is holding a major conference entitled Towards an EU Action Plan on Rare…

💡 #RareDiseaseMoonshot
#RareDisease Moonshot is proud to be part of the movement at the “Towards an EU Action Plan on Rare Diseases” conference (10 April) with a clear message:
❗️ We must act together to address the pressing unmet needs in rare diseases.

🔗 Read more: buff.ly/3oFv6wo

🧵 10/11

3 1 1 0
Post image

💡 #RareDiseaseMoonshot

❗️Public-Private Partnerships (PPPs) in RD research were discussed at the #EURORDIS-RD Europe Round Table of Companies workshop
🔗 buff.ly/2qvPc8R

❗️ Recommendations on reg. science, tools, & platform for supporting start-ups & scale-ups.
🔗 buff.ly/M0QpqnC

🧵 10/11

0 0 1 0
Rare Disease Moonshot welcomes the EU Competitiveness Compass - Rare Disease Moonshot The European Commission’s Competitiveness Compass recognizes biotechnology, life sciences, and innovation as key drivers of economic growth and competitiveness. This communication builds on previous E...

📢 One bonus update today:
Read the #RareDiseaseMoonshot statement about the EU competitiveness compass here:

🔗 www.rarediseasemoonshot.eu/news/rare-di...

#RareDiseases

0 0 0 0
Preview
The Rare Disease Moonshot and Together for Rare Diseases coalitions advocate for reimagining ERNs as research powerhouses with PPPs at their core - Rare Disease Moonshot The European Commission’s recent evaluation of European Reference Networks (ERNs, representing a structured network comprising more than 1,600 highly specialised healthcare units from almost 400…

💡 #RareDiseaseMoonshot and #TogetherForRareDiseases advocate for a transformative vision to reimagine the European Reference Networks (ERNs) as research powerhouses, with public-private partnerships (PPPs) at their core.

🔗 Read more: https://buff.ly/3CDvKHy

🧵 9/10

0 0 1 0